Who are Novo Nordisk A/S's main suppliers?

Novo Nordisk A/S (NONOF) key suppliers include: EXECUTIVE-MANAGEMENT. View the full supplier network at chainsifter.com/chain/NONOF.

Who are Novo Nordisk A/S's major customers?

Novo Nordisk A/S (NONOF) key customers include: HIKMA-PHARMACEUTICALS-PLC, Teva Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, ALVOGEN-INC, APOTEX-INC and 14 more. View the full customer network at chainsifter.com/chain/NONOF.

What sector is Novo Nordisk A/S in?

Novo Nordisk A/S (NONOF) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Novo Nordisk A/S (NONOF) Supply Chain: 21 Verified Relationships

1Suppliers

19Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Novo Nordisk A/S (NONOF) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

21Total relationships

2Distinct source URLs

12High confidence

0.751Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Novo Nordisk A/S Suppliers

Ticker	Name	Confidence	Evidence
EXECUTIVE-MANAGEMENT	EXECUTIVE-MANAGEMENT	62%	s areas, while long-term risks are assessed as part of our company-wide strategic risk identification process. When identifying material climate risks, the same time horizons have been applied as for…

Novo Nordisk A/S Customers

Ticker	Name	Confidence	Evidence
HIKMA-PHARMACEUTICALS-PLC	HIKMA-PHARMACEUTICALS-PLC	90%	Hikma Pharmaceuticals PLC launched its generic liraglutide product in December 2024
TEVA	Teva Pharmaceutical Industries Limited	90%	Reciprocal relationship from TEVA graph: Reciprocal relationship from NONOF graph: Teva launched an authorised generic 7 Novo Nordisk Form 20-F 2025 ITEM 4 INFORMATION ON THE COMPANY version of Victo…
TEVA	Teva Pharmaceutical Industries Limited	90%	Teva launched an authorised generic 7 Novo Nordisk Form 20-F 2025 ITEM 4 INFORMATION ON THE COMPANY version of Victoza ® in June 2024
ALVOGEN-INC	ALVOGEN-INC	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
APOTEX-INC	APOTEX-INC	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
MYLAN-PHARMACEUTICALS-INC	MYLAN-PHARMACEUTICALS-INC	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
RDY	Dr. Reddy's Laboratories Limited	80%	Reciprocal relationship from RDY graph: Reciprocal relationship from NONOF graph: Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), …
RDY	Dr. Reddy's Laboratories Limited	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
RIO-BIOPHARMACEUTICALS-INC	RIO-BIOPHARMACEUTICALS-INC	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
SUN-PHARMACEUTICAL-INDUSTRIES-LIMITED	SUN-PHARMACEUTICAL-INDUSTRIES-LIMITED	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
ZYDUS-PHARMACEUTICALS-INC	ZYDUS-PHARMACEUTICALS-INC	80%	Novo Nordisk has entered into settlement agreements with Alvogen Inc. (Alvogen), Rio Biopharmaceuticals Inc. (Rio ), Sun Pharmaceutical Industries Limited (Sun), Dr. Reddy’s Laboratories, Ltd. (DRL),…
NVO	Novo Nordisk A/S	72%	Item 12D below. B. RELATED PARTY TRANSACTIONS Related parties include the Novo Nordisk Foundation, Novo Holdings A/S, Novonesis A/S, Catalent Group, Innate Pharma SA, Xellia Pharmaceuticals ApS, Alta…
NVO	Novo Nordisk A/S	72%	Reciprocal relationship from NVO graph: Reciprocal relationship from NONOF graph: Item 12D below. B. RELATED PARTY TRANSACTIONS Related parties include the Novo Nordisk Foundation, Novo Holdings A/S,…
A-S-NOVONESIS-A-S-CATALENT-GROUP	A-S-NOVONESIS-A-S-CATALENT-GROUP	62%	Item 12D below. B. RELATED PARTY TRANSACTIONS Related parties include the Novo Nordisk Foundation, Novo Holdings A/S, Novonesis A/S, Catalent Group, Innate Pharma SA, Xellia Pharmaceuticals ApS, Alta…
INNATE-PHARMA-SA-XELLIA-PHARMACEUTICALS-APS-ALTA	INNATE-PHARMA-SA-XELLIA-PHARMACEUTICALS-APS-ALTA	62%	Item 12D below. B. RELATED PARTY TRANSACTIONS Related parties include the Novo Nordisk Foundation, Novo Holdings A/S, Novonesis A/S, Catalent Group, Innate Pharma SA, Xellia Pharmaceuticals ApS, Alta…
NOVO-HOLDINGS	NOVO-HOLDINGS	62%	Item 12D below. B. RELATED PARTY TRANSACTIONS Related parties include the Novo Nordisk Foundation, Novo Holdings A/S, Novonesis A/S, Catalent Group, Innate Pharma SA, Xellia Pharmaceuticals ApS, Alta…
NOVO-NORDISK-FOUNDATION-NOVO-HOLDINGS	NOVO-NORDISK-FOUNDATION-NOVO-HOLDINGS	62%	Item 12D below. B. RELATED PARTY TRANSACTIONS Related parties include the Novo Nordisk Foundation, Novo Holdings A/S, Novonesis A/S, Catalent Group, Innate Pharma SA, Xellia Pharmaceuticals ApS, Alta…
NOVO-NORDISK-GROUP	NOVO-NORDISK-GROUP	62%	Item 12D below. B. RELATED PARTY TRANSACTIONS Related parties include the Novo Nordisk Foundation, Novo Holdings A/S, Novonesis A/S, Catalent Group, Innate Pharma SA, Xellia Pharmaceuticals ApS, Alta…
SINGLE-USE-SUPPORT-GROUP-ELLAB-GROUP	SINGLE-USE-SUPPORT-GROUP-ELLAB-GROUP	62%	Item 12D below. B. RELATED PARTY TRANSACTIONS Related parties include the Novo Nordisk Foundation, Novo Holdings A/S, Novonesis A/S, Catalent Group, Innate Pharma SA, Xellia Pharmaceuticals ApS, Alta…

Novo Nordisk A/S Debt Obligations

Instrument	Description	Confidence	Evidence
NONOF-DEBT	Debt stack $22.8B	90%	Market cache reports total debt of $22.8B.

Novo Nordisk A/S Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Novo Nordisk A/S.

Novo Nordisk A/S Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Novo Nordisk A/S.

Novo Nordisk A/S Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
SDGR	Schrödinger, Inc.	100.00	2
AMRX	Amneal Pharmaceuticals, Inc.	100.00	2
SNYNF	Sanofi	100.00	2
LLY	Eli Lilly and Company	100.00	2
TEVJF	Teva Pharmaceutical Industries Limited	100.00	2
CRBP	Corbus Pharmaceuticals Holdings, Inc.	100.00	2
IPHA	Innate Pharma S.A.	100.00	2
ASND	Ascendis Pharma A/S	100.00	2
HIMS	Hims & Hers Health, Inc.	100.00	2
ALVO	Alvotech	100.00	2
CANF	Can-Fite BioPharma Ltd.	100.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	100.00	2
EVAX	Evaxion A/S	100.00	2
TEVA	Teva Pharmaceutical Industries Limited	60.75	1	['customer']
GYRE	Gyre Therapeutics, Inc.	50.00	2
IMMP	Immutep Limited	50.00	2
ACAD	ACADIA Pharmaceuticals Inc.	50.00	2
DERM	Journey Medical Corporation	50.00	2
MDGL	Madrigal Pharmaceuticals, Inc.	50.00	2
CRNT	Ceragon Networks Ltd.	50.00	2

Novo Nordisk A/S Supply Chain